Pet Deworming Market Scope
Worms can infect pets. Use extreme caution when dealing with pets and their waste. The method of infection varies depending on the type of worm, but can include transmission through breast milk while nursing, skin penetration, and oral ingestion. Gastrointestinal parasites can cause life-threatening anaemia, protein loss from the body, loose motion, vomiting, low glucose in blood, intestinal obstruction, and weight loss in pets. Deworming the pet is an important part of pet care. While nearly 85 percent of kittens and puppies are born with parasitic infections, most animals develop immunity over time. However, illness and stress can weaken the body's response to these parasites and awaken any dormant larvae living in the pet.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Pet Deworming market throughout the predicted period.
Bayer (Germany), Beaphar (Netherlands), Virbac (France), Zoetis Inc., (United States), Krka (Slovenia), Trupanion (United States), Boehringer Ingelheim (Germany), Langley Animal Clinic. (Canada), HomeoPet (United Kingdom) and PetArmor (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Skyec (India), Wiggles (India) and Chewy Inc. (United States).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
The study have segmented the market of Global Pet Deworming market , by Application (Pain Relief & Arthritis, Allergy Relief, Antibiotics and Fleas & Ticks) and Region with country level break-up.
On the basis of geography, the market of Pet Deworming has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
On 27 April 2022, Krka has upgraded its Milprazon dog and cat wormer by introducing it in a chewable format. The broad-spectrum wormer has been improved in a palatable format to make it easier for owners to carry out year-round worming regimes on their dogs and cats. Milprazon Chewable is the first wormer in its category with a proven palatability for dogs based on European Medicines Agency guidelines.
Market Trend
- Rise In Number Of Pet Owners And Increased Spending On Pets
Market Drivers
- Increasing Incidence Of Worm Infection Amongst The Pet
- Rise In Demand For Animal-Based Food Products Fuels The Growth Of Product
Opportunities
- Growing Trend Of Online Purchases In The Pet Deworming Medicines
- Increase In Animal Healthcare Spending
Restraints
- Stringent Government Regulation Regarding To Pet Deworming
Challenges
- Side Effects Associated With Pet Deworming
- Lack Of Awareness In Developing And Under-Developed Regions
Key Target Audience
Pet Deworming Manufacturers, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others